BRD7 anticorps (N-Term)
Aperçu rapide pour BRD7 anticorps (N-Term) (ABIN2212119)
Antigène
Voir toutes BRD7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 76-107, N-Term
-
Réactivité croisée
- Souris
-
Réactivité croisée (Details)
- Calculated cross reactivity: Mo
-
Attributs du produit
- BRD7, NT (BRD7, BP75, CELTIX1, Bromodomain-containing protein 7, 75kD bromodomain protein, Protein CELTIX-1)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- BRD7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 76-107 amino acids from the N-terminal region of human BRD7.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- BRD7 (Bromodomain Containing 7 (BRD7))
-
Autre désignation
- BRD7
-
NCBI Accession
- NP_001167455, NP_037395
-
UniProt
- Q9NPI1
Antigène
-